Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinicsThe program, ...

The Federal Circuit heard oral argument on November 8, 2024, grappling with the issue of what patent claims may properly be listed in the Orange Book. In late 2023, Teva filed a complaint for ...

The goal is for anyone with asthma to have no day or night symptoms, no limitations to activity, no need for a rescue inhaler, normal lung function, and no side effects from treatment. The primary ...